1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:68644 6480464 2 more ... CTD PMID:34391839 1,2-dichloroethane multiple interactions ISO RGD:68645 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in decreased expression of CLDN5 protein] CTD PMID:30081051 1,2-dichloroethane decreases expression ISO RGD:68645 6480464 ethylene dichloride results in decreased expression of CLDN5 protein CTD PMID:30081051 1,2-dimethylhydrazine increases expression ISO RGD:68645 6480464 1, 2-Dimethylhydrazine results in increased expression of CLDN5 mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of CLDN5 mRNA CTD PMID:16142770 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CLDN5 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:68644 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CLDN5 mRNA CTD PMID:20660070 17beta-estradiol decreases expression ISO RGD:68645 6480464 Estradiol results in decreased expression of CLDN5 mRNA CTD PMID:15289156 , PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:68645 6480464 2 more ... CTD PMID:20064788 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:68645 6480464 2 more ... CTD PMID:20064788 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68645 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN5 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN5 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 GDNF protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CLDN5 protein] CTD PMID:26582458 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLDN5 protein CTD PMID:26582458 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 4,4'-sulfonyldiphenol increases expression ISO RGD:68645 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CLDN5 mRNA CTD PMID:30951980 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CLDN5 mRNA CTD PMID:17011747 8-Br-cAMP increases expression ISO RGD:68645 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLDN5 mRNA CTD PMID:20711499 9,10-phenanthroquinone decreases expression ISO RGD:68644 6480464 9, 10-phenanthrenequinone results in decreased expression of CLDN5 mRNA CTD PMID:34391839 9,10-phenanthroquinone multiple interactions ISO RGD:68644 6480464 1 more ... CTD PMID:34391839 acrolein decreases expression ISO RGD:68644 6480464 Acrolein results in decreased expression of CLDN5 mRNA CTD PMID:20525806 acrolein multiple interactions ISO RGD:68645 6480464 [Ovalbumin co-treated with Acrolein] results in increased expression of CLDN5 protein CTD PMID:30608172 acrolein increases expression ISO RGD:68645 6480464 Acrolein results in increased expression of CLDN5 protein CTD PMID:30608172 acrolein multiple interactions ISO RGD:68644 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of CLDN5 mRNA] CTD PMID:20525806 acrolein increases expression ISO RGD:68644 6480464 Acrolein results in increased expression of CLDN5 mRNA CTD PMID:20525806 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CLDN5 mRNA CTD PMID:16483693 ampicillin multiple interactions ISO RGD:68645 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 aripiprazole decreases expression EXP 6480464 Aripiprazole results in decreased expression of CLDN5 mRNA CTD PMID:17868501 arsenous acid multiple interactions ISO RGD:68644 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] CTD PMID:28115242 arsenous acid decreases expression ISO RGD:68644 6480464 Arsenic Trioxide results in decreased expression of CLDN5 protein CTD PMID:28115242 arsenous acid decreases expression ISO RGD:68645 6480464 Arsenic Trioxide results in decreased expression of CLDN5 mRNA CTD PMID:30032600 , PMID:30225639 benzo[a]pyrene increases expression ISO RGD:68644 6480464 Benzo(a)pyrene results in increased expression of CLDN5 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:68644 6480464 Benzo(a)pyrene affects the methylation of CLDN5 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:68645 6480464 Benzo(a)pyrene results in decreased expression of CLDN5 mRNA CTD PMID:19770486 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CLDN5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:68645 6480464 bisphenol A results in increased expression of CLDN5 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:68644 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CLDN5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLDN5 mRNA CTD PMID:30816183 more ... bisphenol A decreases expression ISO RGD:68645 6480464 bisphenol A results in decreased expression of CLDN5 mRNA CTD PMID:25594700 bisphenol F increases expression ISO RGD:68645 6480464 bisphenol F results in increased expression of CLDN5 mRNA CTD PMID:30951980 bucladesine increases expression ISO RGD:68645 6480464 Bucladesine results in increased expression of CLDN5 mRNA CTD PMID:20711499 carbon nanotube decreases expression ISO RGD:68645 6480464 Nanotubes, Carbon analog results in decreased expression of CLDN5 mRNA CTD PMID:25620056 carboxy-PTIO multiple interactions ISO RGD:68644 6480464 1 more ... CTD PMID:34391839 CGP 52608 multiple interactions ISO RGD:68644 6480464 CGP 52608 promotes the reaction [RORA protein binds to CLDN5 gene] CTD PMID:28238834 chlordecone decreases expression ISO RGD:68645 6480464 Chlordecone results in decreased expression of CLDN5 mRNA CTD PMID:33711761 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of CLDN5 mRNA CTD PMID:22611033 chlorpyrifos increases expression ISO RGD:68645 6480464 Chlorpyrifos results in increased expression of CLDN5 mRNA CTD PMID:34289071 , PMID:37019170 choline multiple interactions ISO RGD:68645 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein], NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]] CTD PMID:34416350 ciguatoxin CTX1B affects expression ISO RGD:68645 6480464 Ciguatoxins affects the expression of CLDN5 mRNA CTD PMID:18353800 cypermethrin increases expression ISO RGD:68645 6480464 cypermethrin results in increased expression of CLDN5 mRNA CTD PMID:29020013 deguelin increases expression ISO RGD:68644 6480464 deguelin results in increased expression of CLDN5 mRNA CTD PMID:19861542 deguelin decreases expression ISO RGD:68644 6480464 deguelin results in decreased expression of CLDN5 mRNA CTD PMID:33512557 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 , PMID:32404561 dexamethasone multiple interactions ISO RGD:68644 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in decreased expression of CLDN5 protein]] more ... CTD PMID:28741371 , PMID:32404561 diallyl disulfide decreases expression ISO RGD:68644 6480464 diallyl disulfide results in decreased expression of CLDN5 mRNA, diallyl disulfide results in decreased expression of CLDN5 protein CTD PMID:20600798 diallyl trisulfide decreases expression ISO RGD:68644 6480464 diallyl trisulfide results in decreased expression of CLDN5 mRNA, diallyl trisulfide results in decreased expression of CLDN5 protein CTD PMID:24084732 diarsenic trioxide decreases expression ISO RGD:68644 6480464 Arsenic Trioxide results in decreased expression of CLDN5 protein CTD PMID:28115242 diarsenic trioxide multiple interactions ISO RGD:68644 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] CTD PMID:28115242 diarsenic trioxide decreases expression ISO RGD:68645 6480464 Arsenic Trioxide results in decreased expression of CLDN5 mRNA CTD PMID:30032600 , PMID:30225639 diethylstilbestrol decreases expression ISO RGD:68645 6480464 Diethylstilbestrol results in decreased expression of CLDN5 mRNA CTD PMID:15289156 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CLDN5 mRNA CTD PMID:17011747 diiodine multiple interactions ISO RGD:68644 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 dioxygen multiple interactions ISO RGD:68645 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CLDN5 protein CTD PMID:23876515 dipyridamole increases expression ISO RGD:68645 6480464 Dipyridamole results in increased expression of CLDN5 mRNA CTD PMID:20711499 doxorubicin increases expression ISO RGD:68645 6480464 Doxorubicin results in increased expression of CLDN5 mRNA CTD PMID:19277126 elemental selenium multiple interactions ISO RGD:68644 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 fenthion decreases expression ISO RGD:68645 6480464 Fenthion results in decreased expression of CLDN5 mRNA CTD PMID:34813904 fulvestrant multiple interactions ISO RGD:68644 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CLDN5 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of CLDN5 mRNA CTD PMID:27387713 gamma-linolenic acid multiple interactions ISO RGD:68644 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 genistein decreases expression ISO RGD:68645 6480464 Genistein results in decreased expression of CLDN5 mRNA CTD PMID:15289156 genistein increases expression ISO RGD:68645 6480464 Genistein results in increased expression of CLDN5 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CLDN5 mRNA CTD PMID:22061828 glycine decreases expression ISO RGD:68644 6480464 Glycine results in decreased expression of CLDN5 protein CTD PMID:30605748 glyphosate decreases expression ISO RGD:68644 6480464 glyphosate results in decreased expression of CLDN5 protein CTD PMID:30605748 hydrogen sulfide multiple interactions ISO RGD:68645 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 mRNA, [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 protein CTD PMID:33068716 hydrogen sulfide multiple interactions ISO RGD:68644 6480464 [sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in decreased expression of CLDN5 protein, Dexamethasone inhibits the reaction [[sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in decreased expression of CLDN5 protein] CTD PMID:28741371 hydrogen sulfide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein], Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 , PMID:32404561 hydrogen sulfide decreases expression EXP 6480464 Hydrogen Sulfide results in decreased expression of CLDN5 mRNA, Hydrogen Sulfide results in decreased expression of CLDN5 protein CTD PMID:28741371 , PMID:32404561 L-methionine multiple interactions ISO RGD:68645 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein], NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]] CTD PMID:34416350 lead diacetate decreases expression ISO RGD:68644 6480464 lead acetate results in decreased expression of CLDN5 protein CTD PMID:24200059 lead diacetate multiple interactions ISO RGD:68645 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein CTD PMID:31730887 lead diacetate multiple interactions ISO RGD:68644 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein] CTD PMID:24200059 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of CLDN5 protein CTD PMID:20970449 lead(0) multiple interactions ISO RGD:68645 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein CTD PMID:31730887 lead(0) multiple interactions EXP 6480464 [malaoxon co-treated with Lead] results in decreased expression of CLDN5 protein, [Malathion co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 linsidomine decreases expression ISO RGD:68644 6480464 linsidomine results in decreased expression of CLDN5 protein CTD PMID:34391839 lipopolysaccharide multiple interactions ISO RGD:68644 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLDN5 mRNA CTD PMID:35811015 loxoprofen increases expression ISO RGD:68644 6480464 loxoprofen metabolite results in increased expression of CLDN5 protein more ... CTD PMID:34506768 LY294002 multiple interactions ISO RGD:68644 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of CLDN5 mRNA] more ... CTD PMID:20525806 more ... LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 LY294002 decreases expression ISO RGD:68644 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CLDN5 protein CTD PMID:32404561 LY294002 multiple interactions ISO RGD:68645 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL6 protein results in decreased expression of CLDN5 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in decreased expression of CLDN5 protein] CTD PMID:26025059 malaoxon decreases expression EXP 6480464 malaoxon results in decreased expression of CLDN5 protein CTD PMID:20970449 malaoxon multiple interactions EXP 6480464 [malaoxon co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 malathion multiple interactions EXP 6480464 [Malathion co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 malathion decreases expression EXP 6480464 Malathion results in decreased expression of CLDN5 protein CTD PMID:20970449 medroxyprogesterone acetate increases expression ISO RGD:68644 6480464 Medroxyprogesterone Acetate results in increased expression of CLDN5 mRNA CTD PMID:20843944 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CLDN5 mRNA CTD PMID:19564919 methamphetamine decreases expression ISO RGD:68645 6480464 Methamphetamine results in decreased expression of CLDN5 mRNA, Methamphetamine results in decreased expression of CLDN5 protein CTD PMID:35390362 , PMID:36720452 methamphetamine multiple interactions ISO RGD:68645 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] more ... CTD PMID:35390362 , PMID:36720452 methidathion decreases expression ISO RGD:68645 6480464 methidathion results in decreased expression of CLDN5 mRNA CTD PMID:34813904 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CLDN5 mRNA CTD PMID:34062221 methylmercury chloride multiple interactions EXP 6480464 Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of CLDN5 mRNA] CTD PMID:34062221 metronidazole multiple interactions ISO RGD:68645 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 microcystin-LR decreases expression ISO RGD:68645 6480464 cyanoginosin LR results in decreased expression of CLDN5 protein CTD PMID:34416350 microcystin-LR multiple interactions ISO RGD:68645 6480464 [cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein more ... CTD PMID:34416350 minocycline increases expression EXP 27095946 minocycline increases expression of claudin-5 protein in left corpus callosum of rats with right carotid artery occlusion RGD N-acetyl-L-cysteine multiple interactions ISO RGD:68644 6480464 Acetylcysteine inhibits the reaction [9 more ... CTD PMID:28115242 , PMID:34391839 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:68644 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [9, 10-phenanthrenequinone results in decreased expression of and affects the localization of CLDN5 protein] CTD PMID:34391839 N-methyl-4-phenylpyridinium increases expression ISO RGD:68644 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLDN5 mRNA CTD PMID:24810058 neomycin multiple interactions ISO RGD:68645 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 nickel atom multiple interactions ISO RGD:68644 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CLDN5 mRNA] CTD PMID:14575637 nickel atom decreases expression ISO RGD:68644 6480464 Nickel results in decreased expression of CLDN5 mRNA CTD PMID:25583101 nickel atom affects expression ISO RGD:68644 6480464 Nickel affects the expression of CLDN5 mRNA CTD PMID:14575637 obeticholic acid multiple interactions ISO RGD:68645 6480464 obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:36720452 octhilinone decreases expression ISO RGD:68645 6480464 2-n-octyl-4-isothiazolin-3-one results in decreased expression of CLDN5 protein CTD PMID:33806369 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLDN5 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of CLDN5 mRNA CTD PMID:28549673 ozone multiple interactions ISO RGD:68645 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLDN5 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CLDN5 mRNA CTD PMID:34911549 p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CLDN5 mRNA CTD PMID:17011747 palmitoyl ethanolamide decreases expression ISO RGD:68644 6480464 palmidrol results in decreased expression of CLDN5 mRNA CTD PMID:31054246 papaverine decreases expression EXP 6480464 Papaverine results in decreased expression of CLDN5 protein CTD PMID:20728510 paracetamol affects expression ISO RGD:68645 6480464 Acetaminophen affects the expression of CLDN5 mRNA CTD PMID:17562736 paraquat decreases expression ISO RGD:68645 6480464 Paraquat results in decreased expression of CLDN5 mRNA CTD PMID:21463325 paraquat multiple interactions ISO RGD:68645 6480464 APOD protein affects the reaction [Paraquat results in decreased expression of CLDN5 mRNA] CTD PMID:21463325 perfluorooctanoic acid decreases expression ISO RGD:68645 6480464 perfluorooctanoic acid results in decreased expression of CLDN5 protein CTD PMID:35066053 permethrin multiple interactions ISO RGD:68645 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 mRNA, [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 protein CTD PMID:32832901 phenobarbital affects expression ISO RGD:68645 6480464 Phenobarbital affects the expression of CLDN5 mRNA CTD PMID:19136022 picoxystrobin decreases expression ISO RGD:68644 6480464 picoxystrobin results in decreased expression of CLDN5 mRNA CTD PMID:33512557 pirinixic acid affects expression ISO RGD:68645 6480464 pirinixic acid affects the expression of CLDN5 mRNA CTD PMID:19136022 potassium iodide decreases expression EXP 6480464 Potassium Iodide results in decreased expression of CLDN5 mRNA CTD PMID:32593569 progesterone increases expression ISO RGD:68644 6480464 Progesterone results in increased expression of CLDN5 mRNA CTD PMID:17404688 progesterone multiple interactions ISO RGD:68644 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CLDN5 mRNA CTD PMID:20660070 Pyridostigmine bromide multiple interactions ISO RGD:68645 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 mRNA, [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 protein CTD PMID:32832901 rotenone increases expression ISO RGD:68644 6480464 Rotenone results in increased expression of CLDN5 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68644 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLDN5 mRNA CTD PMID:35811015 sanguinarine decreases expression ISO RGD:68644 6480464 sanguinarine results in decreased expression of CLDN5 protein CTD PMID:19063874 selenium atom multiple interactions ISO RGD:68644 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 silicon dioxide increases expression ISO RGD:68644 6480464 Silicon Dioxide analog results in increased expression of CLDN5 mRNA CTD PMID:23806026 sodium arsenate decreases expression ISO RGD:68645 6480464 sodium arsenate results in decreased expression of CLDN5 mRNA CTD PMID:21795629 sodium sulfide (anhydrous) multiple interactions ISO RGD:68645 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 mRNA, [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 protein CTD PMID:33068716 testosterone affects expression ISO RGD:68645 6480464 Testosterone affects the expression of CLDN5 mRNA CTD PMID:20403060 thifluzamide decreases expression ISO RGD:68644 6480464 thifluzamide results in decreased expression of CLDN5 mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CLDN5 mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CLDN5 mRNA CTD PMID:30012374 toluene increases expression EXP 6480464 Toluene results in increased expression of CLDN5 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLDN5 mRNA CTD PMID:25729387 tributylstannane multiple interactions EXP 6480464 Phycocyanin inhibits the reaction [tributyltin results in decreased expression of CLDN5 protein] CTD PMID:26079211 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of CLDN5 protein CTD PMID:26079211 trichostatin A multiple interactions ISO RGD:68644 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CLDN5 mRNA] CTD PMID:14575637 trimellitic anhydride decreases expression ISO RGD:68645 6480464 trimellitic anhydride results in decreased expression of CLDN5 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression ISO RGD:68645 6480464 triphenyl phosphate results in decreased expression of CLDN5 mRNA CTD PMID:35752650 triptonide increases expression ISO RGD:68645 6480464 triptonide results in increased expression of CLDN5 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:68645 6480464 troglitazone results in increased expression of CLDN5 mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:68644 6480464 Urethane results in decreased expression of CLDN5 mRNA CTD PMID:28818685 vancomycin multiple interactions ISO RGD:68645 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CLDN5 mRNA CTD PMID:19015723
